Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?

J Contemp Brachytherapy · 2026 · PMC13225097 · PMID 42232843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding GI toxicity, the effect of boost type did not reach statistical significance, although a trend in favor of ISBT was observed: OR = 1.78 (0.83-3.83), p = 0.1415 ( Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.